FBXW7 and cancer: Immunohistochemistry revealed that the poorly differentiated cancer tissues were Fbxw7 positive in fewer than 40% of 40 lung adenocarcinoma patients, while 80% of the adjacent nontumor tissues were Fbxw7 positive (Figures 6(a) and 6(b)).